Company intelligence / Profile preview

ReDent Nova

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

ReDent Nova's Self-Adjusting File (SAF) System is approved and marketed for minimally invasive, anatomy-guided root canal shaping and simultaneous irrigation; clinical trial NCT00497042 reported on the safety and efficacy of SAF for root canal treatment[5][6].

Therapeutic areas: Other
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on ReDent Nova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReDent Nova.

Explore the full profile